Bruce Jackson
Stock Analyst at Benchmark
(0.92)
# 3,782
Out of 4,902 analysts
123
Total ratings
27.12%
Success rate
-25.31%
Average return
Main Sectors:
Stocks Rated by Bruce Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFRI Biofrontera | Maintains: Buy | $7 → $2.75 | $0.85 | +223.15% | 8 | May 19, 2025 | |
| HUMA Humacyte | Maintains: Buy | $17 → $14 | $2.42 | +478.51% | 15 | May 14, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $4.5 → $3 | $0.45 | +560.94% | 6 | May 13, 2025 | |
| CLNN Clene | Maintains: Buy | $84 → $33 | $3.90 | +746.15% | 8 | May 8, 2025 | |
| GNLX Genelux | Maintains: Speculative Buy | $25 → $23 | $3.40 | +576.47% | 7 | May 8, 2025 | |
| BLTE Belite Bio | Reiterates: Buy | $80 | $60.99 | +31.17% | 9 | Mar 26, 2025 | |
| NEO NeoGenomics | Reiterates: Hold | n/a | $6.72 | - | 8 | Jan 16, 2025 | |
| EXAS Exact Sciences | Reiterates: Buy | $65 | $52.21 | +24.50% | 7 | Jan 13, 2025 | |
| VNRX VolitionRx | Reiterates: Hold | n/a | $0.68 | - | 3 | Nov 22, 2024 | |
| UNCY Unicycive Therapeutics | Reiterates: Speculative Buy | $30 | $4.65 | +545.16% | 8 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1.25 | $0.63 | +99.08% | 2 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $3 | $1.34 | +123.88% | 3 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $2.00 | +150.00% | 4 | Oct 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $30 | $0.62 | +4,738.71% | 2 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $60 | $4.62 | +1,198.70% | 5 | Aug 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $17 | $0.41 | +4,095.46% | 4 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $24 | $1.08 | +2,122.22% | 3 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $1 | $2.65 | -62.26% | 2 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Speculative Buy | $5 | $0.69 | +622.54% | 4 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.66 | - | 7 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $17.28 | - | 7 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Speculative Buy | $800 | $4.16 | +19,130.77% | 1 | Aug 8, 2022 |
Biofrontera
May 19, 2025
Maintains: Buy
Price Target: $7 → $2.75
Current: $0.85
Upside: +223.15%
Humacyte
May 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $2.42
Upside: +478.51%
Harvard Bioscience
May 13, 2025
Maintains: Speculative Buy
Price Target: $4.5 → $3
Current: $0.45
Upside: +560.94%
Clene
May 8, 2025
Maintains: Buy
Price Target: $84 → $33
Current: $3.90
Upside: +746.15%
Genelux
May 8, 2025
Maintains: Speculative Buy
Price Target: $25 → $23
Current: $3.40
Upside: +576.47%
Belite Bio
Mar 26, 2025
Reiterates: Buy
Price Target: $80
Current: $60.99
Upside: +31.17%
NeoGenomics
Jan 16, 2025
Reiterates: Hold
Price Target: n/a
Current: $6.72
Upside: -
Exact Sciences
Jan 13, 2025
Reiterates: Buy
Price Target: $65
Current: $52.21
Upside: +24.50%
VolitionRx
Nov 22, 2024
Reiterates: Hold
Price Target: n/a
Current: $0.68
Upside: -
Unicycive Therapeutics
Nov 22, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $4.65
Upside: +545.16%
Nov 20, 2024
Reiterates: Speculative Buy
Price Target: $1.25
Current: $0.63
Upside: +99.08%
Oct 11, 2024
Reiterates: Speculative Buy
Price Target: $3
Current: $1.34
Upside: +123.88%
Oct 10, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.00
Upside: +150.00%
Sep 4, 2024
Reiterates: Speculative Buy
Price Target: $30
Current: $0.62
Upside: +4,738.71%
Aug 27, 2024
Reiterates: Speculative Buy
Price Target: $60
Current: $4.62
Upside: +1,198.70%
Aug 26, 2024
Reiterates: Speculative Buy
Price Target: $17
Current: $0.41
Upside: +4,095.46%
Aug 14, 2024
Reiterates: Speculative Buy
Price Target: $24
Current: $1.08
Upside: +2,122.22%
May 29, 2024
Reiterates: Speculative Buy
Price Target: $1
Current: $2.65
Upside: -62.26%
Mar 21, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $0.69
Upside: +622.54%
Nov 14, 2023
Downgrades: Hold
Price Target: n/a
Current: $1.66
Upside: -
Sep 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $17.28
Upside: -
Aug 8, 2022
Initiates: Speculative Buy
Price Target: $800
Current: $4.16
Upside: +19,130.77%